Economic advantage of lateral flow urine lipoarabinomannan assay for tuberculosis diagnosis

Intérêt économique du test urinaire de lipoarabinomannane à flux latéral pour la détection de la tuberculose

Nadia Yakhelef, Martine Audibert (martine.audibert@udamail.fr), Gabrielle Ferlazzo, Joseph Sitienei, Steve Wanjala, Francis Varaine, Maryline Bonnet and Helena Huergac
Additional contact information
Martine Audibert: CERDI - Centre d'Études et de Recherches sur le Développement International - IRD - Institut de Recherche pour le Développement - CNRS - Centre National de la Recherche Scientifique - UCA - Université Clermont Auvergne
Maryline Bonnet: IRD - Institut de Recherche pour le Développement
Helena Huergac: IRD - Institut de Recherche pour le Développement

Post-Print from HAL

Abstract: Tuberculosis is one of the leading causes of death worldwide and the leading cause of death of people with HIV. According to the World Health Organization, 10 million people fall ill with tuberculosis every year [1]. The bacterium is said to be responsible for 1.5 million deaths in 2018, including 250,000 who are HIV positive. To fight this disease, the lateral flow urine lipoarabinomannan test (LF-LAM) is cost-effective and can increase the number of tuberculosis cases detected in HIV-positive immunocompromised patients.

Keywords: Tuberculose; Analyse coût-bénéfice (search for similar items in EconPapers)
Date: 2020-05
Note: View the original document on HAL open archive server: https://uca.hal.science/hal-03513945v1
References: Add references at CitEc
Citations:

Published in 2020

Downloads: (external link)
https://uca.hal.science/hal-03513945v1/document (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-03513945

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD (hal@ccsd.cnrs.fr).